Global Linezolid Market Outlook 2016-2021

Publisher Name :
Date: 09-Oct-2016
No. of pages: 97

Linezolid is an antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to other antibiotics. Linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). The main uses are infections of the skin and pneumonia although it may be use for a variety of other infections.

When administered for short periods, linezolid is a relatively safe antibiotic. It can be used in people of all ages and in people with liver disease or poor kidney function. Common adverse effects of short-term use include headache, diarrhea, and nausea. Long-term use, however, has been associated with serious adverse effects such as bone marrow suppression and low platelet counts, particularly when used for more than two weeks. If used for longer periods still, it may cause sometimes irreversible chemotherapy-induced peripheral neuropathy and optic nerve damage, and lactic acidosis (a buildup of lactic acid in the body), all most likely due to mitochondrial toxicity.

As a protein synthesis inhibitor, it stops the growth of bacteria by disrupting their production of proteins, that is, it is a bacteriostatic agent, not bacteriocidal. Although many antibiotics work this way, the exact mechanism of action of linezolid appears to be unique in that it blocks the initiation of protein production, and not one of the later steps. Bacterial resistance to linezolid has remained very low since it was first detected in 1999, although it may be increasing. It is a member of the oxazolidinone class of drugs.

Linezolid was discovered in the 1990s by a team at Pharmacia and Upjohn Company and first approved for use in 2000. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. Linezolid costs approximately US$100 per tablet in the United States. Nonetheless, it appears to be more cost-effective than generic alternatives such as vancomycin, mostly because of the possibility of switching from intravenous to oral administration as soon as patients are stable enough, without the need for dose adjustments.

This report provides detailed analysis of worldwide markets for Linezolid from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Linezolid market and further lays out an analysis of the factors influencing the supply/demand for Linezolid, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Linezolid Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Linezolid market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Linezolid market are Pfizer (USA), Daewoong (Korea), Glenmark (India), Optimus (India), Symed Labs (India), Amoli (India), Runzhong Pharma (China), Hansoh Pharma (China), Shanghai Acebright (China) , among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Linezolid industry has been provided.

Global Linezolid Market Outlook 2016-2021

Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures

Figure Global Linezolid Production Volume (Unit) 2011-2016
Figure Global Linezolid Production Value (M USD) 2011-2016
Figure Top 10 Linezolid Vendors Production Volume Share 2015
Figure Top 10 Linezolid Vendors Production Value Share 2015
Figure Regional Linezolid Production (Unit) 2015
Figure Regional Linezolid Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Linezolid Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Linezolid Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Linezolid Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Linezolid Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Linezolid Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Linezolid Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Linezolid Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Linezolid Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Linezolid Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Linezolid Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Linezolid Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Linezolid Vendors Production (Unit) 2011-2016
Table Global Key Linezolid Vendors Production Share 2011-2016
Figure Global Linezolid Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Linezolid Vendors Production (Unit) 2011-2016
Table Global Top 10 Linezolid Vendors Production (Unit) 2011
Table Global Top 10 Linezolid Vendors Production (Unit) 2012
Table Global Top 10 Linezolid Vendors Production (Unit) 2013
Table Global Top 10 Linezolid Vendors Production (Unit) 2014
Table Global Top 10 Linezolid Vendors Production (Unit) 2015
Table Global Top 10 Linezolid Vendors Production (Unit) 2016
Figure Linezolid Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Linezolid Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Linezolid Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Linezolid Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Linezolid Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Linezolid Production Value (M USD), Growth Rate
Table Global Key Linezolid Vendors Production Value (M USD) 2011-2016
Table Global Key Linezolid Vendors Production Value Share 2011-2016
Figure Global Top 10 Linezolid Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2011
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2012
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2013
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2014
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2015
Table Global Top 10 Linezolid Vendors Production Value (M USD) 2016
Figure Linezolid Prices (USD/Ton) 2016
Figure Linezolid Gross Margin 2016
Figure Linezolid Production Value (M USD) By Region 2011-2016
Table Global Linezolid Production Value (M USD) 2011-2016
Table Global Linezolid Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Linezolid Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Linezolid Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Linezolid Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Linezolid Production Value Share Trend
Figure Global Linezolid Consumption Volume (Unit) 2015
Table Regional Linezolid Consumption Volume (Unit) 2011-2016
Table Regional Linezolid Consumption Volume Share 2011-2016
Figure Linezolid Consumption in North America 2011-2016
Figure Linezolid Consumption in EMEA 2011-2016
Figure Linezolid Consumption in Asia-Pacific 2011-2016
Figure Linezolid Consumption in ROW 2011-2016
Figure Global Linezolid Consumption Volume (Unit) 2016
Table Global Linezolid Consumption Volume (Unit) 2011-2016
Table Global Linezolid Consumption Volume Share 2011-2016
Figure Global Linezolid Production (Unit) Forecast 2016-2021
Table Global Linezolid Production (Unit) 2016-2021
Table Global Linezolid Production Share 2016-2021
Figure North Linezolid Production (Unit) Forecast 2016-2021
Figure EMEA Linezolid Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Linezolid Production (Unit) Forecast 2016-2021
Figure ROW Linezolid Production (Unit) Forecast 2016-2021
Figure Global Linezolid Revenue (M USD) Forecast 2016-2021
Table Global Linezolid Revenue (M USD) 2016-2021
Table Global Linezolid Revenue Share 2016-2021
Figure North America Linezolid Revenue (M USD) Forecast 2016-2021
Figure EMEA Linezolid Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Linezolid Revenue (M USD) Forecast 2016-2021
Figure ROW Linezolid Revenue (M USD) Forecast 2016-2021
Figure Global Linezolid Consumption Volume (Unit) 2016-2021
Table Global Linezolid Consumption Volume (Unit) 2016-2021
Table Global Linezolid Consumption Volume Share 2016-2021
Figure North America Linezolid Consumption (Unit) Forecast
Figure EMEA Linezolid Consumption (Unit) Forecast
Figure Asia-Pacific Linezolid Consumption (Unit) Forecast
Figure ROW Linezolid Consumption (Unit) Forecast
Figure Global Linezolid Consumption Volume (Unit) 2021
Table Global Linezolid Consumption Volume (Unit) 2016-2021
Table Global Linezolid Consumption Volume Share 2016-2021
Table Key Strategies for Linezolid Multinational Corporations
Table Key Strategies for Linezolid Emerging-Market Players
  • Global Ganciclovir Market Professional Survey Report 2019
    Published: 17-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Ganciclovir market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ganciclovir volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ganciclovir market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import o......
  • Global Chloramphenicol Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 114
    The Chloramphenicol market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Chloramphenicol industrial chain, this report mainly elaborates the definition, types, applications and major players of Chloramphenicol market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developme......
  • Global Drugs For Pseudomonas Aeruginosa Infections Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 133
    The Drugs For Pseudomonas Aeruginosa Infections market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Drugs For Pseudomonas Aeruginosa Infections industrial chain, this report mainly elaborates the definition, types, applications and major players of Drugs For Pseudomonas Aeruginosa Infections market in details. Deep analysis about market status (2014-2019), enterprise competit......
  • Global Drugs For Febrile Neutropenia Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 116
    The Drugs For Febrile Neutropenia market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Drugs For Febrile Neutropenia industrial chain, this report mainly elaborates the definition, types, applications and major players of Drugs For Febrile Neutropenia market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages ......
  • Global Herpes Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 130
    The Herpes market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Herpes industrial chain, this report mainly elaborates the definition, types, applications and major players of Herpes market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024), regi......
  • Global Metronidazole Industry Market Research Report
    Published: 17-Oct-2019        Price: US 2960 Onwards        Pages: 121
    The Metronidazole market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Metronidazole industrial chain, this report mainly elaborates the definition, types, applications and major players of Metronidazole market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development tre......
  • Global Drugs for Toxoplasmosis Market Professional Survey Report 2019
    Published: 16-Oct-2019        Price: US 3500 Onwards        Pages: 101
    The global Drugs for Toxoplasmosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Drugs for Toxoplasmosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Toxoplasmosis market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, appar......
  • Global Amoxicillin Market Growth 2019-2024
    Published: 16-Oct-2019        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Amoxicillin market will register a 0.9% CAGR in terms of revenue, the global market size will reach US$ 4568 million by 2024, from US$ 4410.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Amoxicillin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Amoxicillin market by product type, app......
  • Global and China Ampicillin Market Research by Company, Type & Application 2013-2025
    Published: 15-Oct-2019        Price: US 2000 Onwards        Pages: 74
    Summary Market Segment as follows: By Type - Ampicillin Capsules - Ampicillin Sodium - Ampicillin Granules By Application - Adults - Kids By Company - DSM - ACS Dobfar - Kopran - Antibioticos - United Laboratories - Shandong Lukang Pharmaceutical - CSPC Pharmaceutical - North China Pharmaceutical - Huaxing Pharmaceutical The main con......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs